Review of Research Conducted in Canada
Quorum Review IRB maintains an ethics review board (referred to as the “North American” Board) and serves as both a duly convened research ethics board (REB) as well as a central institutional review board (IRB). The North American Board complies with Canadian and U.S. requirements and meets every Wednesday to review U.S. and Canadian studies. Quorum is AAHRPP-accredited and accepts both privately and publicly funded research in Canada.
Quorum is subject to the same provincial restrictions that apply to other independent REBs. Quorum therefore does not provide review in the provinces of Alberta, Newfoundland and Labrador, and Saskatchewan. In addition, Quorum reviews only studies involving adult participants in the province of Quebec.
Researchers from the U.S. and Canada generally use the same Quorum forms. For the initial submission of a protocol, please use the forms found on the Sponsor > Initial submission page and be sure to check the appropriate box on the Central Study Questionnaire (CSQ) that designates whether the study will be conducted solely in Canada or in both the U.S. and Canada. If your protocol is approved in the U.S. and you want to expand it into Canada, please submit the “Expansion into Canada Central Study Questionnaire” instead of the standard “Central Study Questionnaire.” For site submissions researchers also use the same initial site submission Quorum forms, which are found on the Site > Initial Submission page. Canadian guidelines require that Quorum collect additional paperwork from Canadian investigators, such as a copy of the site’s clinical trial budget. For more information see our FAQs on Canada.
The submission deadline for research activities in Canada (including protocols and protocol amendments) is 5:00 p.m. Pacific Time on Wednesday, one week prior to the meeting. Some site submissions might qualify for expedited review. Quorum will deliver services and turnaround times according to the same timelines in both countries.